Blood Advances
Издатель: Elsevier · ISSN 2473-9529 · 89 статей
- Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron
- Diagnostic accuracy of fat pad sampling and bone marrow biopsy for AL amyloidosis: a systematic review and meta-analysis
- Thrombin-antithrombin complex and fibrinogen predict microangiopathic acute kidney injury in patients with traumatic injuries
- A phase 2a randomized study to evaluate sapablursen in patients with non-transfusion-dependent β-thalassemia intermedia
- Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
- Real-world implementation, feasibility and early effectiveness of blinatumomab for pediatric B-ALL in lower-middle-income countries
- Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial
- Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial
- Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma
- PhenX Toolkit measurement protocols for sickle cell disease pain
- Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma
- Cytokine concentrations in pediatric primary mediastinal large B-cell lymphoma correlate with disease extent and outcome
- Association between patient-reported symptoms and clinical outcomes in R/R CLL
- Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas
- Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis
- Relationship between salvage strategy and outcomes in patients with CBF or NPM1-mutated AML and first molecular relapse
- A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression
- Murine model for congenital dyserythropoietic anemia type I
- Nonanemic iron deficiency in pregnancy: a cross-sectional study of prevalence and predictors
- Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis
- A synthetic, small-molecule, allosteric inhibitor of human factor XIa for thrombosis
- Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders
- Therapeutic timing and molecular properties influence low-molecular-weight heparin efficacy in murine sepsis
- Survival improvement of patients with DLBCL treated with third-line and beyond in the recent era in the Czech Republic
- Factors associated with recurrent episodes of acute chest syndrome in adult patients with sickle cell disease
- Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts
- Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations
- Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study
- Synthetic lethality in TP53-mutated AML